Phase 2 Study of Oral K201 for Prevention of AF Recurrence
Clinical trial NCT01067833 · TERMINATED
Trial details
- NCT number
- NCT01067833
- Sponsor
- Sequel Pharmaceuticals, Inc
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-01
- Primary completion
- 2011-10-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.